6505--Y90-TheraSpheres Radiopharmaceutical, Cleveland
Closed Special Notice Posted
- Solicitation number
- 36C25026Q0043
- Agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, has issued a Special Notice announcing its intent to conduct a sole-source procurement for TheraSphere Y-90 radiopharmaceutical doses. The VA intends to negotiate exclusively with Boston Scientific Corporation of Marlborough, Massachusetts, for the acquisition of TheraSphere Y-90 glass microspheres used in treating unresectable primary Hepatocellular Carcinoma. This therapeutic agent consists of microscopic glass spheres attached to a radioactive isotope (Y-90) that are injected into patients, where the spheres become trapped in the liver to treat liver cancer. The solicitation is designated as 36C25026Q0043 and falls under the authority of FAR 13.5 and 41 U.S.C. A 1901. The VA believes that only one responsible source exists that can satisfy the agency's specific requirements for this specialized medical treatment.
The primary purpose of this Special Notice is to inform the marketplace of the VA's intent to proceed with a sole-source acquisition while providing an opportunity for other potential sources to identify their capabilities. Interested parties have until October 27, 2025, at 9:00 AM EST to submit capability information demonstrating their ability to meet the agency's requirements. All capability responses must be provided at no cost or obligation to the government and should be submitted via email to Contracting Officer Robert Blasko at robert.blasko@va.gov with the subject line "RFQ 36C25026Q0043 TheraSphere Y-90 Nuclear Med." The government retains sole discretion in determining whether to open the procurement to competition based on responses received. Any contractor seeking to participate must demonstrate their capability to provide the specialized Y-90 glass microsphere therapeutic agent that meets the VA's medical requirements for treating liver cancer patients.
Notice text
Page 1 of 1
36C25026Q0043
SPECIAL NOTICE
NOTICE OF INTENT TO SOLE SOURCE
TheraSphere Y-90 Nuclear Med
The Department of Veterans Affairs, The Louis Stokes Cleveland Department of Veteran Affairs Medical Center, 10701 East Boulevard, Cleveland, Ohio 44106 intends to solicit and negotiate with only one source under the authority of FAR 13.5 and 41 U.S.C. § 1901 as implemented by FAR 13.106-1(b)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. The VA intends to solicit and negotiate with Boston Scientific, 300 Boston Scientific Way, Marlborough, MA 01752, for TheraSphere Y-90 Doses.
TheraSphere, Y-90 glass microsphere is a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. It consists of microscopic glass spheres that are attached to a radioactive isotope (Y-90) and then injected into the patient. The spheres are trapped in the liver where they can treat liver cancer.
The Government believes that only one business can satisfy the agency requirements and intends to negotiate with only one source under the authority of FAR 13.5 and 41 U.S.C. § 1901 as implemented by FAR 13.106-1(b)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. Other persons may identify their interest and capability to respond to this requirement by Monday, October 27, 2025 at 9AM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time. All inquiries must be submitted by email to Robert Blasko at robert.blasko@va.gov Enter RFQ 36C25026Q0043 TheraSphere Y-90 Nuclear Med in the email subject line.
Files
| File | Type | Posted |
|---|---|---|
| 36C25026Q0043.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity